• Board voted to proceed with the registry in March, 2015
• Validated the Qualified Clinical Data Registry approach with Large Group Forum, Private Payers, and CMS
• Multiple society interviews
• Formal Request for Proposal
• Vendor selection approved by the Executive Committee, August, 2015
• FIGmd confirmed by the AAO-HNSF Boards September, 2015
• Introduced and promoted at AM in Dallas September 2015
• Reg-ent Executive Committee created in January, 2016
• AAO-HNSF secured both Qualified Clinical Data Registry and PQRS Qualified Registry status from CMS for Reg-ent in April, 2016
• Governance structure operationalized and Clinical Advisory Committees completed in May, 2016
• Agreement with ABOto for MOC
• The recruitment phase of the Reg-ent pilot concluded in June, 2016
• Measures data extraction commenced in June, 2016
• Ongoing discussions with FDA
• Reg-ent opened to full membership for contracting in July, 2016
• Full launch at the AAO-HNSF Annual Meeting and OTO EXPOSM in September, 2016
• Reported 2016 PQRS for Reg-ent practice sites
• Preparing for 2017 MIPS reporting
Data is a critical component in today’s ever-changing healthcare environment. The Reg-ent registry harnesses the power of data to guide the best ENT care. Reg-ent, focused on quality improvement and patient outcomes, is an essential tool that will advance outcomes in the specialty. It will serve as the foundation for Merit-based Incentive Payment System (MIPS) reporting, measures development, research, and contribute to members meeting Maintenance of Certification requirements.
Reg-ent recently received both Qualified Registry (QR) and Qualified Clinical Data Registry (QCDR) designations from CMS for 2017 and many members will in turn be using Reg-ent to report all required MIPS 2017 categories, including Quality Measures, Advancing Care Information (ACI), and Improvement Activities (IA). All Reg-ent participants will also benefit from research being conducted to demonstrate the quality, safety, and efficacy of otolaryngology care.
Sign your contract by July 15, 2017 to partner with Reg-ent for MIPS reporting. The sooner you sign your contract, the more time you will have to integrate your EHR system, review your performance data, and make adjustments as needed in order to maximize your participation. View Academy resources on MIPS as well as the QPP website to learn more and sign your contract with Reg-ent today!
• Board voted to proceed with the registry in March, 2015
James C. Denneny III, MD, Chair
William R. Blythe, MD
Michael G. Glenn, MD
Lisa E. Ishii, MD, MHS
Melissa A. Pynnonen, MD
Richard M. Rosenfeld, MD
Jennifer J. Shin, MD, MS
Lauren S. Zaretsky, MD
Robert P. Miller, MD, Ex-Officio
FIGmd was chosen as our vendor after considerable investigation and consultation with multiple organizations throughout the process. Their model of registry building and implementation has been successful for a number of organizations similar to the AAO-HNS/F including the American College of Cardiology, the American Academy of Ophthalmology, the American Academy of Neurology, the American College of Emergency Physicians and the American Urologic Association. Their systems allow for direct extraction of data from the EHR. All clients of FIGmd have access to innovations and improvements made anywhere in their network. Their vision of shared technology and group participation has allowed a more rapid advancement of registries and their capabilities across a broad range of medical and surgical associations.
FIGmd, Inc. provides clinical data registry analytics and data reporting solutions to medical practices, specialty societies, medical professional associations, hospitals, health systems and others. With minimal impact on workflow, FIGmd’s technologies, solutions and customization capabilities allow organizations to massively scale their projects in a timely and cost-effective manner. For more information on how FIGmd’s solutions can result in productive and actionable data, visit www.figmd.com.
At its core, a registry is a database. Registries can serve a number of purposes. The purpose determines the type of registry that is built, the infrastructure needed for support, and the cost of development. The purpose should align to core member needs. Registries can be built to track new treatments, monitor disease states over time, track population health and patient outcomes, track patients through the care system, and conduct research on new therapies. Some registries are used solely for aftermarket research. Others are used solely for quality improvement and quality reporting. Still others support decision-making at the point of care. The most important step in building a registry is identifying its purpose such that it aligns with member needs and expectations. Reg-ent is being built in modules over time to ultimately offer all of these services.
A very popular form of registry has emerged with the advent of quality reporting for Medicare quality programs and that is a Qualified Clinical Data Registry, or QCDR. We will pursue QCDR designation with CMS. This designation allows for reporting to the Merit-based Incentive Payment System (MIPS). Over time, these registries can grow and add new functionality. Many societies have developed QCDRs jointly with their Boards as collaborators and partners so that physicians may one-stop shop for quality reporting, Maintenance of Certification Part IV, and quality improvement programs. QCDRs house performance measures used for reporting and quality improvement. Reg-ent will take on even more importance as it will facilitate the development of measures across the depth and breadth of Otolaryngology—all of which will be used to document the value of care our members provide both now and into the future.